TAF II p135/p105 Polyclonal Antibody

Alias:TAF4;TAF2C;TAF2C1;TAF4A;TAFII130;TAFII135;Transcription initiation factor TFIID subunit 4;RNA polymerase II TBP-associated factor subunit C;TBP-associated factor 4;Transcription initiation factor TFIID 130 kDa subunit;TAF;II;130;

CatalogNo:HJRLT4527

Specifications

50μL;100μL

Delivery date

Spot

Target

TAF II p135/p105

Reactivity

Human,Mouse

Application - After Update

WB,IHC,IF,ELISA

MW(Observed)

110kD

Host Species

Rabbit

Isotype

IgG

Modify

Unmodified

Recommended dilution ratio

WB 1:500-1:2000;IHC 1:100-1:300;ELISA 1:20000;IF 1:50-200

compose

Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

Store

-15°C to -25°C/1 year(Do not lower than -25°C)

Soncentration

1 mg/ml

Clonality

Polyclonal

Immunogen

The antiserum was produced against synthesized peptide derived from human TAF4. AA range:941-990

Specificity

TAF II p135/p105 Polyclonal Antibody detects endogenous levels of TAF II p135/p105 protein.

Gene name

TAF4/TAF4B

Protein name

Transcription initiation factor TFIID subunit 4/Transcription initiation factor TFIID subunit 4B

Organism-1

Human